Holen Sie sich die Stockscreener-App
5.88
1.20%
0.07
Schlusskurs vom Vortag:
$5.81
Offen:
$5.85
24-Stunden-Volumen:
1.10M
Relative Volume:
0.27
Marktkapitalisierung:
$1.07B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$-171.15M
KGV:
-6.104
EPS:
-0.9633
Netto-Cashflow:
$122.59M
1W Leistung:
+6.14%
1M Leistung:
-10.64%
6M Leistung:
+6.14%
1J Leistung:
-34.23%
1-Tages-Spanne:
$5.76
$5.975
1-Wochen-Bereich:
$5.485
$6.175
52-Wochen-Spanne:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
5.88 | 1.07B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
312.46 | 50.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
69.08 | 12.54B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.41 | 12.35B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
105.36 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.42 | 7.64B | 1.34B | 230.70M | 440.96M | 2.6695 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts - Zacks Investment Research
Holafly lance Ultra, un forfait eSIM international intégrant des services dédiés à la santé et au bien-être - GlobeNewswire Inc.
Should Teladoc’s New AI Tools for Solo Platform Require Action From Teladoc Health (TDOC) Investors? - Yahoo Finance
A fund adviser reports 9.1 million Teladoc Health (TDOC) shares held by its funds. - Stock Titan
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools - Zacks Investment Research
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools - TradingView
Teladoc Health (TDOC) Could Be 63% Undervalued Following Its New AI Tools - Yahoo Finance
Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform - MedCity News
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
AI Tracker: Teladoc launches new AI features - Modern Healthcare
Teladoc unveils remote monitoring, ambient AI features - Healthcare Dive
What's Going On With Teladoc Health Stock Wednesday?Teladoc Health (NYSE:TDOC) - Benzinga
Teladoc Turns Smartphone Cameras Into AI-Powered Vital Sign Monitors - Yahoo Finance
A phone camera can measure a patient's pulse and breathing without touch. Teladoc adds AI visit notes. - Stock Titan
Teladoc Health Expands Solo Connected Care Platform with - GlobeNewswire
3 Undervalued Healthcare Stocks Invstors Can Buy Right Now - The Motley Fool
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Teladoc Health Announces Chief Legal Officer Transition - GlobeNewswire
After 11 years, Teladoc Health's legal chief will leave Nov. 1; Dorfman succeeds him Nov. 2. - Stock Titan
Teladoc Health stock falls 3.46 percent after weak Q2 revenue - ad-hoc-news.de
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research
Teladoc Health stock holds near USD 6.26 as revenue pressure persists - AD HOC NEWS
Teladoc Health CEO Charles Divita sells $108,681 in shares By Investing.com - Investing.com South Africa
Teladoc Health CEO Charles Divita sells $108,681 in shares - Investing.com
The Bull Case For Teladoc Health (TDOC) Could Change Following Weak Q2 Results And Lowered Guidance - finance.yahoo.com
Teladoc Health (TDOC) Slips 2.20% to $6.43, Drifting Toward Key SupportInstitutional Volume - careplusvn.com
Teladoc Share PriceTDOC, RNS News, Articles, Quotes, & Charts (NYSE:TDOC) - Proactive financial news
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life - Seeking Alpha
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - moomoo.com
Why Teladoc (TDOC) Outpaced the Stock Market Today - Yahoo Finance
Teladoc Health (TDOC) executive plans 17.8K-share stock sale - Stock Titan
Avoiding Lag: Real-Time Signals in (TDOC) Movement - Stock Traders Daily
2 Beaten-Down Stocks to Avoid Right Now - The Globe and Mail
2 Beaten-Down Stocks to Avoid Right Now - finance.yahoo.com
2 Beaten-Down Stocks to Avoid Right Now - theglobeandmail.com
Here's Why Teladoc's Integrated Care Business Deserves More Attention - The Globe and Mail
Here's Why Teladoc's Integrated Care Business Deserves More Attention - TradingView
Here's Why Teladoc's Integrated Care Business Deserves More Attention - Yahoo Finance
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - Stock Titan
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - Stock Titan
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - Stock Titan
The Escalator: GSK, Teladoc, FINN Partners and more - Medical Marketing and Media
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - Yahoo Finance
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Teladoc Health Inc-Aktie (TDOC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DIVITA CHARLES III | Officer |
Sep 11 '26 |
Proposed Sale |
6.10 |
17,805 |
108,684 |
0 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 11 '26 |
Sale |
6.10 |
17,805 |
108,682 |
465,535 |
| Rodrigues Fernando M. | Officer |
Sep 03 '26 |
Proposed Sale |
6.51 |
9,812 |
63,876 |
0 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 02 '26 |
Sale |
6.30 |
18,327 |
115,478 |
440,538 |
| Bliss Kelly | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
7,357 |
46,359 |
0 |
| DIVITA CHARLES III | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
18,327 |
115,484 |
0 |
| Nueno Carlos | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
6,200 |
39,068 |
0 |
| Vandervoort Adam C | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
7,573 |
47,720 |
0 |
| Rodrigues Fernando M. | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
5,439 |
34,273 |
0 |
| Nueno Carlos | President, International |
Sep 02 '26 |
Sale |
6.30 |
6,200 |
39,066 |
64,744 |
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):